The Current Ratio as of December 2024 (TTM) for Vaxcyte, Inc. (PCVX) is 17.88

According to Vaxcyte, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 17.88. This represents a change of 17.81% compared to the average of 15.18 of the last 4 quarters.

Vaxcyte, Inc. (PCVX) Historical Current Ratio (quarterly & annually)

How has PCVX Current Ratio performed in the past?

The mean historical Current Ratio of Vaxcyte, Inc. over the last ten years is 10.30. The current 17.88 Current Ratio has changed 17.27% with respect to the historical average. Over the past ten years (40 quarters), PCVX's Current Ratio was at its highest in in the December 2022 quarter at 23.26. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Vaxcyte, Inc. (PCVX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Vaxcyte, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vaxcyte, Inc. (PCVX) Average Current Ratio

How has PCVX Current Ratio performed in the past?

The current Current Ratio of Vaxcyte, Inc. (PCVX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Vaxcyte, Inc. (PCVX) Current Ratio vs. Peers

How is PCVX’s Current Ratio compared to its peers?

Vaxcyte, Inc.’s Current Ratio is greater than Larimar Therapeutics, Inc. (13.10), greater than Syndax Pharmaceuticals, Inc. (6.99), greater than Merus N.V. (8.32), greater than Sutro Biopharma, Inc. (3.09), greater than Arcellx, Inc. (4.29), less than Ventyx Biosciences, Inc. (23.52), greater than Immunocore Holdings plc (3.78), less than DICE Therapeutics, Inc. (38.14), less than Nuvalent, Inc. (23.07), less than Viridian Therapeutics, Inc. (18.55), greater than Legend Biotech Corporation (4.98), greater than Apellis Pharmaceuticals, Inc. (4.36), greater than Travere Therapeutics, Inc. (1.71), greater than Akero Therapeutics, Inc. (17.25), greater than BioMarin Pharmaceutical Inc. (4.27), greater than Liquidia Corporation (6.33), greater than Bio-Techne Corporation (4.56),

Build a custom stock screener for Vaxcyte, Inc. (PCVX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaxcyte, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vaxcyte, Inc. (PCVX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vaxcyte, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.